JP2011507915A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507915A5
JP2011507915A5 JP2010540046A JP2010540046A JP2011507915A5 JP 2011507915 A5 JP2011507915 A5 JP 2011507915A5 JP 2010540046 A JP2010540046 A JP 2010540046A JP 2010540046 A JP2010540046 A JP 2010540046A JP 2011507915 A5 JP2011507915 A5 JP 2011507915A5
Authority
JP
Japan
Prior art keywords
oxo
phenyl
ethoxy
carbonyl
pyrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010540046A
Other languages
English (en)
Japanese (ja)
Other versions
JP5504171B2 (ja
JP2011507915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/010572 external-priority patent/WO2009080226A2/en
Publication of JP2011507915A publication Critical patent/JP2011507915A/ja
Publication of JP2011507915A5 publication Critical patent/JP2011507915A5/ja
Application granted granted Critical
Publication of JP5504171B2 publication Critical patent/JP5504171B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010540046A 2007-12-26 2008-12-12 P2y12アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド Expired - Fee Related JP5504171B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07291627 2007-12-26
EP07291627.3 2007-12-26
PCT/EP2008/010572 WO2009080226A2 (en) 2007-12-26 2008-12-12 Heterocyclic pyrazole-carboxamides as p2y12 antagonists

Publications (3)

Publication Number Publication Date
JP2011507915A JP2011507915A (ja) 2011-03-10
JP2011507915A5 true JP2011507915A5 (https=) 2012-02-02
JP5504171B2 JP5504171B2 (ja) 2014-05-28

Family

ID=39521970

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010540046A Expired - Fee Related JP5504171B2 (ja) 2007-12-26 2008-12-12 P2y12アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド

Country Status (4)

Country Link
US (1) US8426420B2 (https=)
EP (1) EP2238128B1 (https=)
JP (1) JP5504171B2 (https=)
WO (1) WO2009080226A2 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2225253B1 (en) 2007-11-29 2012-06-27 Actelion Pharmaceuticals Ltd. Phosphonic acid derivates and their use as p2y12 receptor antagonists
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
MA33260B1 (fr) 2009-04-08 2012-05-02 Actelion Pharmaceuticals Ltd 6-(3-azabicyclo[3.1.0.]hex-3-yl)-2-phenylpyrimidines
CA2756654C (en) 2009-04-22 2017-08-22 Actelion Pharmaceuticals Ltd Thiazole derivatives and their use as p2y12 receptor antagonists
TWI532725B (zh) 2010-01-26 2016-05-11 賽諾菲阿凡提斯公司 經氧取代之3-雜芳醯基胺基-丙酸衍生物及其作為藥物之用途
TWI523844B (zh) 2011-01-26 2016-03-01 賽諾菲公司 經胺基取代之3-雜芳醯基胺基-丙酸衍生物及其作為藥物之用途
AR085013A1 (es) 2011-01-26 2013-08-07 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos y su uso como sustancias farmaceuticas
FR2974576B1 (fr) * 2011-04-29 2013-07-19 Sanofi Aventis Derives de n-[(1h-pyrazol-1-yl)aryl]-1h-indole ou 1h- indazole-3-carboxamide, leur preparation et leurs applications en therapeutique
MY169319A (en) 2011-07-26 2019-03-21 Sanofi Sa 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
KR20140049020A (ko) 2011-07-26 2014-04-24 사노피 치환된 3-(티아졸-4-카보닐)- 또는 3-(티아졸-2-카보닐)아미노프로피온산 유도체 및 이의 약제로서의 용도
US9539246B2 (en) 2011-08-30 2017-01-10 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
WO2013072328A1 (en) 2011-11-14 2013-05-23 Sanofi Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases
US20130123325A1 (en) 2011-11-14 2013-05-16 Sven Ruf Use of boceprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases
US9630945B2 (en) 2012-12-19 2017-04-25 Novartis Ag Autotaxin inhibitors
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
SG11201506190QA (en) 2013-03-28 2015-09-29 Sanofi Sa Biaryl-propionic acid derivatives and their use as pharmaceuticals
TW201522318A (zh) 2013-03-28 2015-06-16 Sanofi Sa 聯芳基丙酸及其作為醫藥品之用途
CN104109158A (zh) * 2013-04-16 2014-10-22 上海医药工业研究院 一种纯化利伐沙班的方法
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
CN107759662B (zh) * 2013-08-28 2020-10-30 北京赛而生物药业有限公司 一种抗凝血化合物、其制备方法和用途、及包含其的药物组合物
US9231217B2 (en) 2013-11-28 2016-01-05 Semiconductor Energy Laboratory Co., Ltd. Synthesis method of organometallic complex, synthesis method of pyrazine derivative, 5,6-diaryl-2-pyrazyl triflate, light-emitting element, light-emitting device, electronic device, and lighting device
EP3515924B1 (en) 2016-09-22 2021-12-15 Idorsia Pharmaceuticals Ltd Crystalline forms
MA49887A (fr) 2017-03-15 2020-06-24 Idorsia Pharmaceuticals Ltd Administration sous-cutanée d'un antagoniste du récepteur p2y12
US12396970B2 (en) 2021-08-20 2025-08-26 AltaThera Pharmaceuticals LLC Anti-arrhythmic compositions and methods
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
JP7684282B2 (ja) 2020-03-31 2025-05-27 田辺三菱製薬株式会社 ヒドロキシピロリジン誘導体およびその医薬用途
CN115429874A (zh) * 2022-09-20 2022-12-06 暨南大学 水蛭素靶向并抑制dpp4治疗糖尿病
CN119930579A (zh) * 2025-01-15 2025-05-06 四川轻化工大学 哌啶环类化合物及其合成方法、药学上可接受的盐与应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5621359A (en) * 1995-07-27 1997-04-15 Lucent Technologies Inc. Gain selection technique
TW536540B (en) 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
ZA985247B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
WO2000077027A2 (en) 1999-06-14 2000-12-21 Tularik Limited Serine protease inhibitors
HUP0104634A3 (en) 1998-07-06 2002-11-28 Bristol Myers Squibb Co Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6861424B2 (en) * 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
CN104744461A (zh) 2001-09-21 2015-07-01 百时美施贵宝公司 含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂
CA2511321A1 (en) * 2002-12-23 2004-07-08 Aventis Pharma Deutschland Gmbh Pyrazole-derivatives as factor xa inhibitors
GB0309637D0 (en) * 2003-04-28 2003-06-04 Cancer Rec Tech Ltd Pyrazole compounds
AU2003249865A1 (en) 2003-06-24 2005-01-21 Actelion Pharmaceuticals Ltd Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors
TW200526641A (en) * 2003-12-26 2005-08-16 Daiichi Seiyaku Co Amidopyrazole derivatives
US7441581B2 (en) * 2005-03-10 2008-10-28 3M Innovative Properties Company Adhesive tape applicator
TW200640877A (en) * 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives

Similar Documents

Publication Publication Date Title
JP2011507915A5 (https=)
US6627629B2 (en) N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
TWI409261B (zh) 經取代之苯甲醯胺衍生物
JP2006528940A5 (https=)
JP2010539152A5 (https=)
DE602004006431D1 (de) Derivate von n-äheteroaryl(piperidin-2-yl)methylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
JP2016536333A5 (https=)
ES2505190T3 (es) Derivados de piperidina como antagosistas del receptor nk3
CN1893945A (zh) 作为趋化因子受体调控剂的3-环烷基氨基吡咯烷衍生物
RU2013157374A (ru) Производное индазола и пирролопиридина и его фармацевтическое применение
AU2009314827A1 (en) Melanocortin receptor agonists
JP2008501752A (ja) Dpp−iv阻害剤
RU2010106974A (ru) Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3
CA2623043A1 (en) Isoxazolo derivatives as gaba a alpha5 inverse agonists
CN1419541A (zh) 作为bax抑制剂的药物活性的吡咯烷衍生物
JP2010529069A (ja) Nk3アンタゴニストとしてのプロリンアミド誘導体
ES2494065T3 (es) Derivados de pirrolidina
RU2008149927A (ru) Производные 1-[(4-[ензоил(метил)амино]-3-(фенил)бутил]азетидина для лечения желудочно-кишечных расстройств
RU2014136573A (ru) Новые производные пирролидина
RU2561271C2 (ru) Производные пирролидина в качестве антагонистов рецептора nk-3
CA2449578A1 (en) Pyrrolidine oxadiazole- and thiadiazole derivatives
RU2006100730A (ru) Цис-2, 4, 5-триарил-имидазолины
RU2664644C2 (ru) Новые производные тетразолона
JP2010530380A5 (https=)
AU2010215513A1 (en) Pyrrolidine derivatives as NK3 receptor antagonists